POSSIBLE STRATEGIES FOR IMPLEMENTATION OF THE WHO PROGRAM ON THE ELIMINATION OF HEPATITIS C IN UKRAINE BY 2030

Apply

POSSIBLE STRATEGIES FOR IMPLEMENTATION OF THE WHO PROGRAM ON THE ELIMINATION OF HEPATITIS C IN UKRAINE BY 2030

Journal Title: Гепатологія - Year 2017, Vol 38, Issue 4

Abstract

Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. Morbidity and mortality attributable to chronic HCV infection are increasing as the infected population ages. New treatment options are becoming available, and there is a need to characterize the epidemiology and disease burden of HCV. Model has been used to forecast the progression of liver disease and to estimate the total burden and changes in HCV sequelae over time with the natural history and under the infl uence of treatment. Model was developed to quantify and characterize the viremic population, as well as the number of new infections and HCV related deaths from 2000 to 2030. Possible strategies for the implementation of the WHO program should be presented for the elimination of hepatitis C in Ukraine by 2030. Increasing levels of diagnosis and treatment, in combination with improved treatment effi cacy, were critical for achieving substantial reductions in disease burden. In Ukraine, the number of annually treated population had to increase several fold to achieve the largest reductions in HCV-related morbidity and mortality. To achieve the goals of the WHO elimination program, it is necessary to treat at least 50% of the population with hepatitis C in Ukraine. Th is suggests that increased capacity for screening and treatment will be critical for Ukraine.

Authors and Affiliations

I. Zaytsev, V. Potii

Keywords

INVESTIGATION OF INFLUENCE OF INTRADERMAL IMMUNIZATION WITH INACTIVATED AUTOLEUKOCYTES ON THE CONDITION OF ANTIVIRAL IMMUNITY IN PATIENTS WITH CHRONIC HEPATITIS B

Data about infl uence of autoleukocyte immunization with inactivated autoleukocytes on the condition of delayed-type hypersensitivity in relation to HBV antigens have been presented in the article. Th e investigation...

CHANGES OF ANTIMITOCHONDRIAL ANTIBODY LEVELS IN PATIENTS WITH CHRONIC HEPATITIS C DURING TREATMENT AND THEIR ASSOCIATION WITH CLINICAL-LABORATORY AND EPIDEMIOLOGICAL DATA

Analyzing autoantibodies level of the patients with chronic hepatitis C who were on antiviral therapy with interferon drugs, the increase in the number of patients with elevated amount of antimitochondrial antibodies (...

EP ID EP251874
DOI -
Views 91
Downloads 0